{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T06:21:49Z","timestamp":1745648509658,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12094-018-1995-0","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T05:05:02Z","timestamp":1543554302000},"page":"881-890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer"],"prefix":"10.1007","volume":"21","author":[{"given":"A.","family":"Fondevilla Soler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-3751","authenticated-orcid":false,"given":"J. L.","family":"L\u00f3pez-Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Samaniego Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Belmonte Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Praena-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rivin del Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Azinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"issue":"7","key":"1995_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s12094-016-1607-9","volume":"19","author":"J Galceran","year":"2017","unstructured":"Galceran J, Ameijide A, Carulla M, Mateos A, Quiros JR, Rojas D, et al. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017;19(7):799\u2013825. \n                    https:\/\/doi.org\/10.1007\/s12094-016-1607-9\n                    \n                  .","journal-title":"Clin Transl Oncol"},{"key":"1995_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.oraloncology.2017.04.005","volume":"70","author":"A Rueda","year":"2017","unstructured":"Rueda A, Giralt J, Manos M, Lozano A, Sistiaga A, Garcia-Miragall E, et al. Multidisciplinary management of head and neck cancer: first expert consensus using Delphi methodology from the Spanish society for head and neck cancer (part 2). Oral Oncol. 2017;70:65\u201372. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2017.04.005\n                    \n                  .","journal-title":"Oral Oncol."},{"issue":"3","key":"1995_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","volume":"91","author":"S Marur","year":"2016","unstructured":"Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386\u201396. \n                    https:\/\/doi.org\/10.1016\/j.mayocp.2015.12.017\n                    \n                  .","journal-title":"Mayo Clin Proc."},{"issue":"3","key":"1995_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0167-8140(01)00449-2","volume":"61","author":"KS Chao","year":"2001","unstructured":"Chao KS, Majhail N, Huang CJ, Simpson JR, Perez CA, Haughey B, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001;61(3):275\u201380.","journal-title":"Radiother Oncol."},{"issue":"2","key":"1995_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0167-8140(02)00172-X","volume":"64","author":"F Claus","year":"2002","unstructured":"Claus F, Boterberg T, Ost P, De Neve W. Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome? Radiother Oncol. 2002;64(2):205\u20138.","journal-title":"Radiother Oncol."},{"issue":"1","key":"1995_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijrobp.2003.10.032","volume":"59","author":"A Eisbruch","year":"2004","unstructured":"Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59(1):28\u201342. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2003.10.032\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"1995_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1368-8375(00)00063-4","volume":"37","author":"BS Henson","year":"2001","unstructured":"Henson BS, Inglehart MR, Eisbruch A, Ship JA. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol. 2001;37(1):84\u201393.","journal-title":"Oral Oncol"},{"issue":"2","key":"1995_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","volume":"12","author":"CM Nutting","year":"2011","unstructured":"Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127\u201336. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(10)70290-4\n                    \n                  .","journal-title":"Lancet Oncol."},{"issue":"2","key":"1995_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ijrobp.2010.10.061","volume":"82","author":"S Clavel","year":"2012","unstructured":"Clavel S, Nguyen DH, Fortin B, Despres P, Khaouam N, Donath D, et al. Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2012;82(2):582\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2010.10.061\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"1995_CR10","doi-asserted-by":"publisher","first-page":"XC01","DOI":"10.7860\/jcdr\/2016\/21457.8583","volume":"10","author":"G Ghosh","year":"2016","unstructured":"Ghosh G, Tallari R, Malviya A. Toxicity profile of IMRT vs. 3D-CRT in head and neck cancer: a retrospective study. J Clin Diagn Res. 2016;10(9):XC01\u20133. \n                    https:\/\/doi.org\/10.7860\/jcdr\/2016\/21457.8583\n                    \n                  .","journal-title":"J Clin Diagn Res."},{"issue":"4","key":"1995_CR11","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ijrobp.2008.10.054","volume":"73","author":"M Feng","year":"2009","unstructured":"Feng M, Kong FM, Gross M, Fernando S, Hayman JA, Ten Haken RK. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys. 2009;73(4):1228\u201334. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2008.10.054\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1995_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/raon-2013-0071","volume":"49","author":"S Jelercic","year":"2015","unstructured":"Jelercic S, Rajer M. The role of PET-CT in radiotherapy planning of solid tumours. Radiol Oncol. 2015;49(1):1\u20139. \n                    https:\/\/doi.org\/10.2478\/raon-2013-0071\n                    \n                  .","journal-title":"Radiol Oncol."},{"issue":"1","key":"1995_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13014-017-0850-8","volume":"12","author":"B Dobler","year":"2017","unstructured":"Dobler B, Obermeier T, Hautmann MG, Khemissi A, Koelbl O. Simultaneous integrated boost therapy of carcinoma of the hypopharynx\/larynx with and without flattening filter-a treatment planning and dosimetry study. Radiat Oncol. 2017;12(1):114. \n                    https:\/\/doi.org\/10.1186\/s13014-017-0850-8\n                    \n                  .","journal-title":"Radiat Oncol."},{"key":"1995_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13014-014-0264-9","volume":"9","author":"A Merlotti","year":"2014","unstructured":"Merlotti A, Alterio D, Vigna-Taglianti R, Muraglia A, Lastrucci L, Manzo R, et al. Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology-head and neck working group. Radiat Oncol. 2014;9:264. \n                    https:\/\/doi.org\/10.1186\/s13014-014-0264-9\n                    \n                  .","journal-title":"Radiat Oncol."},{"issue":"5","key":"1995_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341\u20136. \n                    https:\/\/doi.org\/10.1016\/0360-3016(95)00060-C\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"1995_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.radonc.2013.11.010","volume":"110","author":"GN Marta","year":"2014","unstructured":"Marta GN, Silva V, de Andrade Carvalho H, de Arruda FF, Hanna SA, Gadia R, et al. Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis. Radiother Oncol. 2014;110(1):9\u201315. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2013.11.010\n                    \n                  .","journal-title":"Radiother Oncol."},{"issue":"1","key":"1995_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","volume":"48","author":"KK Fu","year":"2000","unstructured":"Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48(1):7\u201316.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"1995_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.oraloncology.2017.04.004","volume":"70","author":"M Manos","year":"2017","unstructured":"Manos M, Giralt J, Rueda A, Cabrera J, Martinez-Trufero J, Marruecos J, et al. Multidisciplinary management of head and neck cancer: first expert consensus using Delphi methodology from the Spanish society for head and neck cancer (part 1). Oral Oncol. 2017;70:58\u201364. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2017.04.004\n                    \n                  .","journal-title":"Oral Oncol."},{"issue":"9208","key":"1995_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","volume":"355","author":"JP Pignon","year":"2000","unstructured":"Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. Meta-analysis of chemotherapy on head and neck cancer. Lancet. 2000;355(9208):949\u201355.","journal-title":"Lancet"},{"issue":"2","key":"1995_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijrobp.2007.12.046","volume":"72","author":"KE Rusthoven","year":"2008","unstructured":"Rusthoven KE, Raben D, Chen C. Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality. Int J Radiat Oncol Biol Phys. 2008;72(2):343\u201350. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2007.12.046\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"1995_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13014-016-0756-x","volume":"12","author":"G Vlacich","year":"2017","unstructured":"Vlacich G, Stavas MJ, Pendyala P, Chen SC, Shyr Y, Cmelak AJ. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer. Radiat Oncol. 2017;12(1):13. \n                    https:\/\/doi.org\/10.1186\/s13014-016-0756-x\n                    \n                  .","journal-title":"Radiat Oncol."},{"issue":"10","key":"1995_CR22","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/cncr.29241","volume":"121","author":"DI Rosenthal","year":"2015","unstructured":"Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS, et al. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey. Cancer. 2015;121(10):1608\u201319. \n                    https:\/\/doi.org\/10.1002\/cncr.29241\n                    \n                  .","journal-title":"Cancer"},{"issue":"7","key":"1995_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12094-015-1417-5","volume":"18","author":"BC Ferreira","year":"2016","unstructured":"Ferreira BC, Sa-Couto P, Lopes MC, Khouri L. Compliance to radiation therapy of head and neck cancer patients and impact on treatment outcome. Clin Transl Oncol. 2016;18(7):677\u201384. \n                    https:\/\/doi.org\/10.1007\/s12094-015-1417-5\n                    \n                  .","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"1995_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00066-017-1160-7","volume":"193","author":"S Ursino","year":"2017","unstructured":"Ursino S, D\u2019Angelo E, Mazzola R, Merlotti A, Morganti R, Cristaudo A, et al. A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy: a systematic review by the Italian head and neck radiotherapy study group. Strahlenther Onkol. 2017;193(11):877\u201389. \n                    https:\/\/doi.org\/10.1007\/s00066-017-1160-7\n                    \n                  .","journal-title":"Strahlenther Onkol."},{"issue":"1","key":"1995_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/COC.0b013e31823a538e","volume":"36","author":"F Hoebers","year":"2013","unstructured":"Hoebers F, Yu E, Eisbruch A, Thorstad W, O\u2019Sullivan B, Dawson LA, et al. A pragmatic contouring guideline for salivary gland structures in head and neck radiation oncology: the MOIST target. Am J Clin Oncol. 2013;36(1):70\u20136. \n                    https:\/\/doi.org\/10.1097\/COC.0b013e31823a538e\n                    \n                  .","journal-title":"Am J Clin Oncol."},{"issue":"3","key":"1995_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.radonc.2009.09.008","volume":"93","author":"TA Water van de","year":"2009","unstructured":"van de Water TA, Bijl HP, Westerlaan HE, Langendijk JA. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol. 2009;93(3):545\u201352. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2009.09.008\n                    \n                  .","journal-title":"Radiother Oncol."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1995-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-018-1995-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1995-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T19:06:37Z","timestamp":1575054397000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-018-1995-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1995"],"URL":"https:\/\/doi.org\/10.1007\/s12094-018-1995-0","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"20 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare that we do not have any financial support or relationships that may suppose conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All research was carried out in compliance with the Helsinki Declaration and in accordance with Spanish law. This study was approved by our institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of retrospective study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}